REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,198,612 | -15.6% | 801,973 | -18.5% | 0.00% | -33.3% |
| Q2 2023 | $26,308,492 | +215.7% | 983,495 | +155.6% | 0.00% | +200.0% |
| Q1 2023 | $8,333,403 | +3.5% | 384,737 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $8,050,589 | +62.2% | 337,976 | +34.2% | 0.00% | 0.0% |
| Q3 2022 | $4,964,000 | +5.2% | 251,764 | +4.0% | 0.00% | 0.0% |
| Q2 2022 | $4,718,000 | -1.5% | 242,030 | +28.9% | 0.00% | 0.0% |
| Q1 2022 | $4,790,000 | +289.1% | 187,769 | +283.8% | 0.00% | – |
| Q4 2021 | $1,231,000 | -55.2% | 48,926 | -51.1% | 0.00% | – |
| Q3 2021 | $2,750,000 | -83.5% | 99,983 | -81.0% | 0.00% | -100.0% |
| Q2 2021 | $16,708,000 | +128.6% | 526,418 | +230.4% | 0.00% | +100.0% |
| Q1 2021 | $7,310,000 | +511.2% | 159,345 | +427.2% | 0.00% | – |
| Q4 2020 | $1,196,000 | -34.1% | 30,227 | -42.1% | 0.00% | – |
| Q3 2020 | $1,816,000 | +93.4% | 52,184 | +75.4% | 0.00% | – |
| Q2 2020 | $939,000 | -9.8% | 29,753 | -37.4% | 0.00% | – |
| Q1 2020 | $1,041,000 | – | 47,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |